Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

Autor: Zucca, Emanuele ^*, Rondeau, Stephanie, Vanazzi, Anna, Østenstad, Bjørn, Mey, Ulrich J.M., Rauch, Daniel, Wahlin, Björn E., Hitz, Felicitas, Hernberg, Micaela, Johansson, Ann-Sofie, de Nully Brown, Peter, Hagberg, Hans, Ferreri, Andrés J.M., Lohri, Andreas, Novak, Urban, Zander, Thilo, Bersvendsen, Hanne, Bargetzi, Mario, Mingrone, Walter, Krasniqi, Fatime, Dirnhofer, Stefan, Hayoz, Stefanie, Hawle, Hanne, Vilei, Simona Berardi, Ghielmini, Michele, Kimby, Eva

Publikováno v: In Blood 25 July 2019 134(4):353-362

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study

Autor: Lia, Kjersti, R.K. Jørgensen, Rasmus, Wold, Bente Loftum, Fluge, Øystein, Fagerli, Unn Merete, Bersvendsen, Hanne Skjerven, Bø, Idun Bakke, Bhargava, Sameer, Fosså, Alexander

Publikováno v: Lia, Kjersti R.K. Jørgensen, Rasmus Wold, Bente Loftum Fluge, Øystein Fagerli, Unn Merete Bersvendsen, Hanne Skjerven Bø, Idun Bakke Bhargava, Sameer Fosså, Alexander . Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study. Haematologica. 2023, 00(xx)
Haematologica

Externí odkaz: http://hdl.handle.net/10852/108956

Work ability and work status changes in long-term Hodgkin lymphoma survivors with focus on late adverse effects

Autor: Dahl, Alv A, Smeland, Knut Bjøro, Eikeland, Siri Asheim, Fagerli, Unn Merete, Bersvendsen, Hanne Skjerven, Fosså, Alexander, Kiserud, Cecilie E.

Publikováno v: Dahl, Alv A Smeland, Knut Bjøro Eikeland, Siri Asheim Fagerli, Unn Merete Bersvendsen, Hanne Skjerven Fosså, Alexander Kiserud, Cecilie E. . Work ability and work status changes in long-term Hodgkin lymphoma survivors with focus on late adverse effects. Jo
Jo

Externí odkaz: http://hdl.handle.net/10852/108649